Assignee
NOVELMED THERAPEUTICS INC
US·14 granted patents·9 pending applications·33 citations·filing 2003–2024
Top patents by PatentIndex Score
23 records- 0187US9243070B2Humanized and chimeric anti-factor Bb antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2013·Granted Jan 26, 2016·10 cites·17 claims
- 0283US9676842B2Anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·2 cites·4 claims
- 0382US9988441B2Methods of treating hemolytic disorders comprising administering anti-Bb antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Granted Jun 5, 2018·3 cites·13 claims
- 0481US9243060B2Humanized anti-factor C3b antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2013·Granted Jan 26, 2016·5 cites·15 claims
- 0580US10131706B2Anti-factor Bb antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Granted Nov 20, 2018·2 cites·12 claims
- 0680US7959919B2Method of inhibiting factor B-mediated complement activationNOVELMED THERAPEUTICS INC·Filed 2003·Granted Jun 14, 2011·6 cites·17 claims
- 0779US10696740B2Methods of treating ocular diseasesNOVELMED THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·1 cites·17 claims
- 0876US10858420B2Methods of treating hemolytic disorders comprising administering an anti-C3b antibodyNOVELMED THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·1 cites·13 claims
- 0976US2025042981A1Monospecific and bispecific antibodies and antigen binding fragments thereofNOVELMED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1075US10183989B2Methods of treating ocular diseasesNOVELMED THERAPEUTICS INC·Filed 2014·Granted Jan 22, 2019·1 cites·20 claims
- 1172US10711056B2Aglycosylated anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2012·Granted Jul 14, 2020·1 cites·7 claims
- 1271US9926366B2Methods of treating a hemolytic disorder comprising administering anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2013·Granted Mar 27, 2018·1 cites·16 claims
- 1367US11981727B2Monospecific and bispecific antibodies and antigen binding fragments thereofNOVELMED THERAPEUTICS INC·Filed 2021·Granted May 14, 2024·0 cites·8 claims
- 1463US9566297B2Methods and compositions for inhibiting cellular proliferation and surgical adhesionNOVELMED THERAPEUTICS INC·Filed 2014·Granted Feb 14, 2017·0 cites·14 claims
- 1559US2014127204A1Anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1657US9816999B2Neo antibodies for diagnostic imaging of tissue injuryNOVELMED THERAPEUTICS INC·Filed 2015·Granted Nov 14, 2017·0 cites·18 claims
- 1752US2016244513A1Method of inhibiting complement activation with human anti-factor c3 antibodies and uses thereofNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1847US2014186348A1Humanized and chimeric anti-properdin antibodiesNOVELMED THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1942US2016207987A1Alternative pathway specific antibodies for treating arthritisNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2042US2018000932A1Formulation of aglycosylated therapeutic antibodiesNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2141US2015216876A1Method for treating inflammatory conditionsNOVELMED THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2239US2018002408A9AGLYCOSYLATED ANTI-Bb ANTIBODIES AND USES THEREOFNOVELMED THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2339US2019202898A9AGLYCOSYLATED ANTI-C3b ANTIBODIES AND USES THEREOFNOVELMED THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOVELMED THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →